TNDMS - The National Diabetes Management Strategy
You are using a browser that is not standards-compliant (possibly Netscape 4). The information on this Web site will be accessible to you, but for a list of Web browsers that comply with the World Wide Web Consortium standards, please visit our Web standards page.
General Inquiries:
Toll-free 1-855-858-6872
t: 519-661-2111 ext. 22102
f: 519-858-5029
e: jackie.mclellan@schulich.uwo.ca

 

CDA Chair Diabetes Management ...

Message from the Chair

 


Stewart B. Harris,

CM, MD, MPH, FCFP, FACPM
CDA Chair in
Diabetes Management
 
 

Research Focus of the National Diabetes Management Strategy

Since my re-appointment as the CDA Chair for the next five years, I will continue the 10-year mandate initially proposed. I look forward to continuing the comprehensive diabetes research program under the auspices of the CDA Chair in Diabetes Management at Western University.  I believe in the potential of the CDA Chair to identify and reduce clinical care gaps and optimize the management of diabetes as a means of improving the quality of care for people living with diabetes.

I will provide leadership for the strategy and revised goals and objectives of the NDMS Chair after assessing the strengths, challenges and achievements from the first five years as CDA Chair of Diabetes Management, and understanding the current and emerging issues and critical care gaps in diabetes prevention and management. Moving forward with innovation and leadership, the Chair activities will include research, training and professional development, advocacy initiatives, and knowledge translation.

To meet the CDA Chair mandate and goal/objectives of the NDMS, the research program focuses on four priority research areas that fulfill the concept of continuity and expansion of the NDMS:

  1. Evaluation of Diabetes and Chronic Disease Models of Care
  2. Diabetes Research with First Nations
  3. Pragmatic Studies in Diabetes Care
  4. Clinical and Administrative Research Databases
  5. Investigator Initiated and Pharmaceutical Sponsored Clinical Trials

As the Chair I have continued to provide a leadership role supporting the Canadian Diabetes Association’s 2013 clinical practice guideline and I consult for various sectors of Health Canada including the Aboriginal Diabetes Initiative, a national program associated with the First Nations and Inuit Health, with regards to their policies and programs for First Nations diabetes care and with the Public Health Agency of Canada, on the editorial board for the Diabetes in Canada: Facts and Figures from a public health perspective.



Sincerely,

Stewart Harris, CM, MD, MPH, FCFP, FACPM